Will Spooren is section head of behavioral pharmacology and preclinical imaging at Hoffman-La Roche and coordinator of EU-AIMS.
Will Spooren
Head of behavioral pharmacology and preclinical imaging
F. Hoffmann-La Roche
From this contributor
Questions for Will Spooren: Paving a path to autism drugs
A European initiative that aims to provide a framework for clinical trials in autism has developed tools to track treatment responses.
Questions for Will Spooren: Paving a path to autism drugs
Explore more from The Transmitter
AI-assisted coding: 10 simple rules to maintain scientific rigor
These guidelines can help researchers ensure the integrity of their work while accelerating progress on important scientific questions.
AI-assisted coding: 10 simple rules to maintain scientific rigor
These guidelines can help researchers ensure the integrity of their work while accelerating progress on important scientific questions.
Glutamate receptors, mRNA transcripts and SYNGAP1; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 15 December.
Glutamate receptors, mRNA transcripts and SYNGAP1; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 15 December.
Frameshift: Shari Wiseman reflects on her pivot from science to publishing
As chief editor of Nature Neuroscience, Wiseman applies critical-thinking skills she learned in the lab to manage the journal’s day-to-day operations.
Frameshift: Shari Wiseman reflects on her pivot from science to publishing
As chief editor of Nature Neuroscience, Wiseman applies critical-thinking skills she learned in the lab to manage the journal’s day-to-day operations.